Innate Therapeutics Receives Funding For Clinical Trial Of Progressive Multiple Sclerosis Therapeutic Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase [...]
Allos Therapeutics Reports First Quarter 2010 Financial Results WESTMINSTER, Colo.—-Allos Therapeutics, Inc. today reported financial results for the first quarter ended March 31, 2010. Read more on Business Wire via Yahoo! Finance Share and Enjoy:
Continue reading about Allos Therapeutics Reports First Quarter 2010 Financial Results



















